<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "Covid-19"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.03.933226v4">Link</a></p><p><b>Date:</b> 2020-02-04</p><p><b>Authors:</b> Syed Faraz Ahmed ... Matthew R. McKay</p><p><b>Downloads:</b> 2857</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The beginning of 2020 has seen the emergence of COVID-19 outbreak caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).  There is an imminent need to better understand this new virus and to develop ways to control its spread.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.03.932350v3">Link</a></p><p><b>Date:</b> 2020-02-04</p><p><b>Authors:</b> Gurjit S. Randhawa ... Lila Kari</p><p><b>Downloads:</b> 1593</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> As of February 20, 2020, the 2019 novel coronavirus (renamed to COVID-19) spread to 30 countries with 2130 deaths and more than 75500 confirmed cases.  COVID-19 is being compared to the infamous SARS coronavirus, which resulted, between November 2002 and July 2003, in 8098 confirmed cases worldwide with a 9.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivorsâ€™ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.25.963546v2">Link</a></p><p><b>Date:</b> 2020-02-27</p><p><b>Authors:</b> CV Herst ... R Rubsamen</p><p><b>Downloads:</b> 247</p><p><b>Relevance Score:</b> 1.0</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The 2013-2016 West Africa EBOV epidemic was the biggest EBOV outbreak to date.  An analysis of virus-specific CD8+ T-cell immunity in 30 survivors showed that 26 of those individuals had a CD8+ response to at least one EBOV protein.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.07.939389v3">Link</a></p><p><b>Date:</b> 2020-02-11</p><p><b>Authors:</b> Linlin Bao ... Chuan Qin</p><p><b>Downloads:</b> 4318</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Severe acute respiratory syndrome CoV-2 (SARS-CoV-2) caused the Corona Virus Disease 2019 (COVID-19) cases in China has become a public health emergency of international concern (PHEIC).  Based on angiotensin converting enzyme 2 (ACE2) as cell entry receptor of SARS-CoV, we used the hACE2 transgenic mice infected with SARS-CoV-2 to study the pathogenicity of the virus.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Molecular Modeling Evaluation of the Binding Effect of Ritonavir, Lopinavir and Darunavir to Severe Acute Respiratory Syndrome Coronavirus 2 Proteases</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.01.31.929695v2">Link</a></p><p><b>Date:</b> 2020-02-03</p><p><b>Authors:</b> Shen Lin ... Xushun Guo</p><p><b>Downloads:</b> 1397</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Three anti-HIV drugs, ritonavir, lopinavir and darunavir, might have therapeutic effect on coronavirus disease 2019 (COVID-19).  In this study, the structure models of two severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteases, coronavirus endopeptidase C30 (CEP\_C30) and papain like viral protease (PLVP), were built by homology modeling.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Multivariate Analyses of Codon Usage of SARS-CoV-2 and other betacoronaviruses</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.02.15.950568v3">Link</a></p><p><b>Date:</b> 2020-02-20</p><p><b>Authors:</b> Haogao Gu ... Leo L.M. Poon</p><p><b>Downloads:</b> 372</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Coronavirus disease 2019 (COVID-19) is a global health concern as it continues to spread within China and beyond.  The causative agent of this disease, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), belongs to the genus Betacoronavirus which also includes severe acute respiratory syndrome related coronavirus (SARSr-CoV) and Middle East respiratory syndrome related coronavirus (MERSr-CoV).</p></div></td></div><td></td></tr></table></div><hr></div></body></html>